Skip to Content

UHS News Release
Release:  Immediately
Contact:  Jon Tooley, 762-2336 or

Published on May 06, 2014

New Technology Enhances UHS Breast Center Care

Fast, informed clinical decisions are essential to outstanding patient care.  At UHS, new technology in the pathology laboratories is helping doctors to quickly and precisely report the prognostic markers of breast cancer, enabling them to more quickly, consistently and effectively determine treatment and prognosis for patients with breast cancer. 

UHS pathologist Jagmohan Sidhu, MD, the lab’s medical director, is enthusiastic about the region’s only whole slide brightfield scanner packaged with advanced image management software. This is a leap forward in pathology technology which allows UHS doctors to make a “quick prognostic and predictive marker work-up” of biopsied tissue samples and determine the right course of treatment and prognosis for breast cancer patients. 

Dr. Sidhu explained that “prognostication” is the identification of factors that affect survival in a patient with cancer. Identification of prognostic factors in breast cancer patients helps the oncologists also to decide whether some of the medications should be used or shouldn’t be used to treat the cancer. “The beauty of this system is that our pathologists here at UHS are now able to do this in a matter of one or two days instead of the previous turnaround time of up to 10 days when we had to send these biopsies for prognostic/predictive marker analysis to an outside lab. And we know that improved turnaround time in prognostication helps relieve anxiety for our patients and enables our providers to plan the treatment more quickly for better outcomes.” 

Camelia Lawrence, MD, FACS, fellowship-trained breast surgeon at UHS Breast Center at UHS Vestal, agrees. “The benefits of this new pathology tool cannot be overstated.  The addition of this technology benefits both doctor and patient.  The doctor receives essential, complete information much more quickly, which enables the patient to begin appropriate treatments more quickly, too.”  

Michael J. Farrell, MD, FACS, medical director of UHS Breast Center, stated, “We at the Breast Center rely upon our pathology department for their diagnostic expertise, and this new technology along with our outstanding pathology staff are essential to the prompt diagnosis and treatment we offer breast cancer patients.” 

In addition to state-of-the-art image management technology, UHS Breast Center offers complete screening and diagnostic services for breast cancer and other breast conditions, including digital mammography examinations, ultrasound testing, and both ultrasound-guided and stereotactic biopsy. They offer surgical and non-surgical breast care including treatment of benign and malignant breast processes, as well as comprehensive cancer care services.  For more information, contact UHS Breast Center at UHS Vestal at 607-763-5523

UHS is a locally owned, not-for-profit, 916-bed hospital and healthcare system serving Greater Binghamton and surrounding counties. Founded in 1981, UHS provides a full range of medical, surgical, rehabilitative and long-term care services from more than 60 locations around New York’s Southern Tier.

Follow the latest UHS news and more on Facebook ( and Twitter (